Insulin-stimulated glucose uptake in C2C12 myoblasts.

D. Mangnall,C. Bruce,R. Fraser

DOI: https://doi.org/10.1042/BST021438S

1993-11-01

Biochemical Society Transactions

Abstract:

What problem does this paper attempt to address?

Successful Β Cells Islet Regeneration in Streptozotocin-Induced Diabetic Baboons Using Ultrasound-Targeted Microbubble Gene Therapy with Cyclind2/cdk4/glp1

Shuyuan Chen,Raúl A. Bastarrachea,Brad J. Roberts,V. Saroja Voruganti,Patrice A. Frost,Edna J. Nava‐González,Héctor Eliud Arriaga-Cázares,Jiaxi Chen,Pintong Huang,Ralph A. DeFronzo,Anthony G. Comuzzie,Paul Grayburn

DOI: https://doi.org/10.4161/cc.27997

2014-01-01

Abstract:Both major forms of diabetes mellitus (DM) involve β-cell destruction and dysfunction. New treatment strategies have focused on replenishing the deficiency of β-cell mass common to both major forms of diabetes by islet transplantation or β-cell regeneration. The pancreas, not the liver, is the ideal organ for islet regeneration, because it is the natural milieu for islets. Since islet mass is known to increase during obesity and pregnancy, the concept of stimulating pancreatic islet regeneration in vivo is both rational and physiologic. This paper proposes a novel approach in which non-viral gene therapy is targeted to pancreatic islets using ultrasound targeted microbubble destruction (UTMD) in a non-human primate model (NHP), the baboon. Treated baboons received a gene cocktail comprised of cyclinD2, CDK, and GLP1, which in rats results in robust and durable islet regeneration with normalization of blood glucose, insulin, and C-peptide levels. We were able to generate important preliminary data indicating that gene therapy by UTMD can achieve in vivo normalization of the intravenous (IV) glucose tolerance test (IVGTT) curves in STZ hyperglycemic-induced conscious tethered baboons. Immunohistochemistry clearly demonstrated evidence of islet regeneration and restoration of β-cell mass.
Successful β cells islet regeneration in streptozotocin-induced diabetic baboons using ultrasound-targeted microbubble gene therapy with cyclinD2/CDK4/GLP1.

Shuyuan Chen,Raul A Bastarrachea,Brad J Roberts,V Saroja Voruganti,Patrice A Frost,Edna J Nava-Gonzalez,Hector E Arriaga-Cazares,Jiaxi Chen,Pintong Huang,Ralph A DeFronzo,Anthony G Comuzzie,Paul A Grayburn

DOI: https://doi.org/10.4161/cc.27997

2014-01-01

Abstract:Both major forms of diabetes mellitus (DM) involve β-cell destruction and dysfunction. New treatment strategies have focused on replenishing the deficiency of β-cell mass common to both major forms of diabetes by islet transplantation or β-cell regeneration. The pancreas, not the liver, is the ideal organ for islet regeneration, because it is the natural milieu for islets. Since islet mass is known to increase during obesity and pregnancy, the concept of stimulating pancreatic islet regeneration in vivo is both rational and physiologic. This paper proposes a novel approach in which non-viral gene therapy is targeted to pancreatic islets using ultrasound targeted microbubble destruction (UTMD) in a non-human primate model (NHP), the baboon. Treated baboons received a gene cocktail comprised of cyclinD2, CDK, and GLP1, which in rats results in robust and durable islet regeneration with normalization of blood glucose, insulin, and C-peptide levels. We were able to generate important preliminary data indicating that gene therapy by UTMD can achieve in vivo normalization of the intravenous (IV) glucose tolerance test (IVGTT) curves in STZ hyperglycemic-induced conscious tethered baboons. Immunohistochemistry clearly demonstrated evidence of islet regeneration and restoration of β-cell mass.
Glucose Sensing by Skeletal Myocytes Couples Nutrient Signaling to Systemic Homeostasis.

Zhuo-Xian Meng,Jianke Gong,Zhimin Chen,Jingxia Sun,Yuanyuan Xiao,Lin Wang,Yaqiang Li,Jianfeng Liu,X. Z. Shawn Xu,Jiandie D. Lin

DOI: https://doi.org/10.1016/j.molcel.2017.04.007

IF: 16

2017-01-01

Molecular Cell

Abstract:Skeletal muscle is a major site of postprandial glucose disposal. Inadequate insulin action in skeletal myocytes contributes to hyperglycemia in diabetes. Although glucose is known to stimulate insulin secretion by β cells, whether it directly engages nutrient signaling pathways in skeletal muscle to maintain systemic glucose homeostasis remains largely unexplored. Here we identified the Baf60c-Deptor-AKT pathway as a target of muscle glucose sensing that augments insulin action in skeletal myocytes. Genetic activation of this pathway improved postprandial glucose disposal in mice, whereas its muscle-specific ablation impaired insulin action and led to postprandial glucose intolerance. Mechanistically, glucose triggers KATP channel-dependent calcium signaling, which promotes HDAC5 phosphorylation and nuclear exclusion, leading to Baf60c induction and insulin-independent AKT activation. This pathway is engaged by the anti-diabetic sulfonylurea drugs to exert their full glucose-lowering effects. These findings uncover an unexpected mechanism of glucose sensing in skeletal myocytes that contributes to homeostasis and therapeutic action.
A Transgenic Mouse Model to Study Glucose Transporter 4myc Regulation in Skeletal Muscle

Schertzer Jonathan D,Antonescu Costin N,Bilan Philip J,Jain Swati,Huang Xudong,Liu Zhi,Bonen Arend,Klip Amira

DOI: https://doi.org/10.1210/en.2008-1372

IF: 5.051

2009-01-01

Endocrinology

Abstract:Skeletal muscle is the major site for dietary glucose disposal, taking up glucose via glucose transporter 4 (GLUT4). Although subcellular fractionation studies demonstrate that insulin increases GLUT4 density in sarcolemma and transverse tubules, fractionation cannot discern GLUT4 vesicle-membrane association from insertion and exofacial exposure. Clonal muscle cultures expressing exofacially tagged GLUT4 have allowed quantification of GLUT4 exposure at the cell surface, its exocytosis, endocytosis, and partner proteins. We hypothesized that transgenic expression of GLUT4myc in skeletal muscles would provide a useful model to investigate GLUT4 biology in vivo. A homozygous mouse colony was generated expressing GLUT4myc driven by the muscle creatine kinase (MCK) promoter. GLUT4 protein levels were about 3-fold higher in hindlimb muscles of MCK-GLUT4myc transgenic mice compared with littermates (P < 0.05). Insulin (12 nM, 30 min) induced a 2.1-fold increase in surface GLUT4myc detected by immunofluorescence of the exofacial myc epitope in nonpermeabilized muscle fiber bundles (P < 0.05). Glucose uptake and surface GLUT4myc levels were 3.5- and 3-fold higher, respectively, in giant membrane vesicles blebbed from hindlimb muscles of insulin-stimulated transgenic mice compared with unstimulated counterparts (P < 0.05). Muscle contraction also elevated both parameters, an effect partially additive to insulin's. GLUT4myc immunoprecipitation with anti-myc antibodies avoids interfering with associated intracellular binding proteins. Tether, containing a UBX domain, for GLUT4 coimmunoprecipitated with GLUT4myc and insulin stimulation significantly decreased such association (P < 0.05). MCK-GLUT4myc transgenic mice are thus useful to quantify exofacial GLUT4 exposure at the sarcolemma and GLUT4 binding partners in skeletal muscle, essential elements in the investigation of muscle GLUT4 regulation in physiological and pathological states in vivo. (Endocrinology 150: 1935-1940, 2009)
Insulin-triggered repositioning of munc18c on syntaxin-4 in GLUT4 signalling

Natalie P Smithers,Conrad P Hodgkinson,Matt Cuttle,Graham J Sale

DOI: https://doi.org/10.1042/BJ20070802

2008-03-01

Abstract:One of the most important actions of insulin is the stimulation of the uptake of glucose into fat and muscle cells. Crucial to this response is the translocation of GLUT4 (glucose transporter-4) to the plasma membrane. The insulin-stimulated GLUT4 vesicle docking at the plasma membrane requires an interaction between VAMP-2 (vesicle-associated membrane protein-2) on the GLUT4 vesicle and syntaxin-4 in the plasma membrane. In the basal state, munc18c is thought to preclude GLUT4 vesicle docking by inhibiting this interaction. Here, we have used FCS (fluorescence correlation spectroscopy) in single living cells to show that munc18c binds to syntaxin-4 in both the basal and insulin-stimulated states. We show that munc18c contains two binding sites for syntaxin-4, one of which is disrupted by insulin, while the other is activated by insulin. Insulin-triggered repositioning of munc18c on syntaxin-4 in this way in turn allows syntaxin-4 to adopt its 'open' conformation and bind VAMP-2, resulting in the docking of the GLUT4 vesicle at the cell surface. The results also demonstrate the utility of using FCS in intact single living cells to elucidate cell signalling events.
In vivo effects of focused shock waves on tumor tissue visualized by fluorescence staining techniques.

P. Lukeš,J. Zeman,V. Horák,P. Hoffer,P. Poučková,M. Holubová,S. Hosseini,H. Akiyama,P. Šunka,J. Beneš

DOI: https://doi.org/10.1016/j.bioelechem.2014.08.019

IF: 5.76

2015-06-01

Bioelectrochemistry

Abstract:
Method for the Detection of Insulin‐independent Glucose Uptake in Skeletal Muscle

Natalie J. Norman,Julio A. Landero-Figueroa,Judith J. Heiny

DOI: https://doi.org/10.1096/fasebj.2020.34.s1.00300

2020-04-01

The FASEB Journal

Abstract:The quantification of glucose uptake into tissues, alongside co‐solutes flux, is essential to advance basic knowledge of glucose transport and metabolism. However, comprehensive understanding of glucose metabolism has been elusive. A major player in this crucial process is muscle tissue ‐ its large mass, high catabolic rate and storage capabilities make a major contribution to glucose homeostasis. The traditional insulin‐dependent model has proven insufficient to explain a well‐documented clinical observation: Type II diabetic, insulin resistant patients can lower their blood sugar levels with frequent exercise. One challenge in studying a complex mechanism like glucose uptake in muscles is the lack of experimental tools with multi‐channel capabilities, able to quantify most of, if not all the possible related solute fluxes within current models, in‐vivo or ex‐vivo. Our goal was to develop a method to measure glucose, K+, Na+, Ca2+, Fe, Cu, Zn2+ and Mn flux in biological samples using Inductively Coupled Plasma – Mass Spectroscopy (ICP‐MS). ICP‐MS is well established as a sensitive and versatile tool for direct detection and quantification of specific elements. In this study, we developed a new ratiometric method, based on stable‐isotope dilution, to quantify 13C‐based molecules using the molar ratio of 13C/12C. This, added to the multi‐metal detection capabilities of ICP‐MS was combined for a multi‐channel ion flux measurement in mouse EDL muscle during contraction‐stimulated glucose uptake. The preliminary results demonstrated a correlation of K+ uptake with glucose uptake. We showed involvement of the Na+K+ATPase (NKA) with this process using ouabain. An isolated EDL muscle was either stimulated at 90 Hz for 5 min or left unstimulated in 11mM 13C glucose uptake solution at 32°C. The muscle was then washed at 0°C for 20 minutes to wash away excess glucose on the surface of the muscle and to inhibit transporter activity. The muscle was then digested in 1:1 HCl and H2SO4 to break it down to inorganic forms. Finally, we used ICP‐MS to quantify glucose and co‐solute transport. The transport rate for glucose (nM/g min) for stimulated tissues was 601 as compared to 9 for unstimulated tissues. The stimulated muscles also took up K+, as measured through Rb+ tracer, indicating that NKA was active during contraction‐stimulated glucose uptake. To determine which isoform of Na,K,ATPase (NKA) the glucose was coupled to, we used 0.75uM ouabain. This concentration is enough to maintain muscle contractions as well as inhibit NKA α2 but not α1. Ouabain reduced the average glucose uptake rate by 81 %. These preliminary results show that NKA α2 may be coupled to a possible novel glucose transporter in skeletal muscle tissue or to GLUT‐4 in an undescribed way. The development of a method to measure glucose concentrations in biological samples together with coupled fluxes of other ions will advance knowledge of glucose handling in health and disease. In addition, our method to reproducibly quantify C‐based organic molecules by ICP‐MS will advance applications of ICP‐MS to many other fields of biomedical research. NIH RO1 AR 063710
Development of a Novel GLUT4 Translocation Assay for Identifying Potential Novel Therapeutic Targets for Insulin Sensitization.

Franklin Liu,Qing Dallas-Yang,Gino Castriota,Paul Fischer,Francesca Santini,Marc Ferrer,Jing Li,Taro E. Akiyama,Joel P. Berger,Bei B. Zhang,Guoqiang Jiang

DOI: https://doi.org/10.1042/bj20082051

IF: 3.766

2008-01-01

Biochemical Journal

Abstract:GLUT4 (glucose transporter 4) plays important roles in glucose homoeostasis in vivo. GLUT4 expression and function are diminished in diabetic human and animal subjects. The goal of the present study is to develop a cell-based assay for identifying negative regulators of GLUT4 translocation as potential targets for the treatment of Type 2 diabetes. Traditional GLUT4 translocation assays performed in differentiated myocytes or adipocytes are difficult to perform, particularly in HTS (high-throughput screening) mode. In the present study, we stably co-expressed c-Myc and eGFP [enhanced GFP (green fluorescent protein)] dual-tagged recombinant GLUT4 with recombinant IRS1 (insulin receptor substrate 1) in HEK-293 cells (human embryonic kidney cells) (HEK-293.IRS1.GLUT4 cells). Insulin treatment stimulated both glucose uptake and GLUT4 translocation in these cells. GLUT4 translocation is quantified by a TRF (time-resolved fluorescence) assay in a 96-well HTS format. TRF assays confirmed insulin-stimulated GLUT4 translocation, which can be inhibited by PI3K (phosphoinositide 3-kinase) or Akt [also called PKB (protein kinase B)] inhibitors. Treatment with palmitate increased IRS1 serine phosphorylation and reduced insulin-stimulated Akt phosphorylation and GLUT4 translocation, indicating insulin resistance. Knockdown of PTEN (phosphatase and tensin homologue deleted on chromosome 10) and PTP1B (protein tyrosine phosphatase 1B) gene expression by siRNA (small interfering RNA) treatment significantly increased GLUT4 translocation only in cells treated with palmitate but not in untreated cells. Similar results were obtained on treatment with siRNA of JNK1 (c-Jun N-terminal kinase 1), S6K1 (ribosomal protein S6 kinase, 70 kDa, polypeptide 1) and PKC(theta) (protein kinase C theta). In summary, we have established and validated a novel GLUT4 translocation assay that is optimal for identifying negative regulators of GLUT4 translocation. In combination with more physiologically relevant secondary assays in myotubes and adipocytes, this assay system can be used to identify potential novel therapeutic targets for the treatment of Type 2 diabetes.
Assessment of Tissue-Specific Glucose Uptake: Teaching an Old 2-DOG New Tricks

Max C Petersen,Michael J Jurczak,Max C. Petersen,Michael J. Jurczak

DOI: https://doi.org/10.2337/db23-0816

IF: 7.7

2024-02-22

Diabetes

Abstract:A major function of insulin in skeletal muscle, heart, and white and brown adipose tissue is to stimulate cellular glucose uptake (1). Tissue-specific measurements of insulin-stimulated glucose uptake are useful for dissecting the mechanisms underlying abnormalities detected by tests of whole-body glucose homeostasis, such as the glucose or insulin tolerance test. Several methods using isotope-labeled, nonmetabolizable glucose tracers are available for assessing tissue-specific glucose uptake in vivo, including [ 18 F]fluorodeoxyglucose (FDG) positron emission tomography (2) and bolus injection of [ 14 C]2-deoxyglucose (2-DOG) during a hyperinsulinemic-euglycemic clamp (3). These tracers behave like glucose and enter the cell by facilitated diffusion via GLUT transporters. Following uptake, 2-DOG is phosphorylated by hexokinase but cannot be metabolized further by the glycolytic machinery. The phosphorylated glucose tracer is therefore trapped in cell types that do not express glucose-6-phosphatase, enabling measurement of tissue-specific glucose uptake. However, these techniques require specialized equipment, demand procedural expertise, and are generally low throughput (4). They also measure glucose uptake under one condition (e.g., basal or insulin stimulated), limiting data interpretation.

endocrinology & metabolism
Molecular basis for insulin-stimulated GLUT4 translocation

Debbie C. Thurmond,Jeffrey E. Pessin

DOI: https://doi.org/10.1097/00060793-200104000-00003

2001-04-01

Abstract:In muscle and adipose tissues, the clearance of circulating glucose depends upon the insulin-stimulated translocation of the glucose transporter GLUT4 isoform from its intracellular compartment(s) to the cell surface. This translocation process involves four basic steps, beginning with the activation of the intrinsic tyrosine kinase activity of the insulin receptor: the stimulation of complex sets of effector molecules generating various signaling cascades, the movement/trafficking of intracellular GLUT4 storage compartments toward the plasma membrane, docking of these compartments with the cell surface membrane, and the ultimate fusion of these compartments with the plasma membrane allowing the facilitative entry of glucose into the cell. Although these four stages of GLUT4 translocation are generally well accepted, the molecular details and specific proteins involved in these discreet events have remained highly elusive. Advances have recently been made in identifying new signaling pathways and effector proteins that may link signaling to the activation of vesicle trafficking.

English Else
Bi-directional transport of GLUT4 vesicles near the plasma membrane of primary rat adipocytes.

Ying-Ke Xu,Ke-Di Xu,Jie-Yue Li,Lin-Qing Feng,Di Lang,Xiao-Xiang Zheng

DOI: https://doi.org/10.1016/j.bbrc.2007.05.075

IF: 3.1

2007-01-01

Biochemical and Biophysical Research Communications

Abstract:Insulin stimulates glucose uptake into adipocytes by mobilizing intracellular membrane vesicles containing GLUT4 proteins to the plasma membrane. Here we applied time-lapse total internal reflection fluorescence microscopy to study moving parameters and characters of exogenously expressed GLUT4 vesicles in basal, insulin and nocodazole treated primary rat adipocytes. Our results showed that microtubules were essential for long-range transport of GLUT4 vesicles but not obligatory for GLUT4 distribution in rat adipocytes. Insulin reduced the mobility of the vesicles, made them tethered/docked to the PM and finally had constitutive exocytosis. Moreover, long-range bi-directional movements of GLUT4 vesicles were visualized for the first time by TIRFM. It is likely that there are interactions between insulin signaling and microtubules, to regulating GLUT4 translocation in rat adipocytes.
Glucose transporters are key components of the human glucostat

Inbal Caspi,Daniel M Tremmel,Julian Pulecio,Dapeng Yang,Dingyu Liu,Jielin Yan,Jon S Odorico,Danwei Huangfu

DOI: https://doi.org/10.2337/db23-0508

IF: 7.7

2024-05-23

Diabetes

Abstract:Mouse models are extensively utilized in metabolic studies. However, inherent differences between the species, notably their blood glucose levels, hampered data translation into clinical settings. In this study, we confirmed GLUT1 to be the predominantly expressed glucose transporter in both adult and fetal human β cells. In comparison, GLUT2 is detected in a small yet significant subpopulation of adult β cells and is expressed to a greater extent in fetal β cells. Notably, GLUT1/2 expression in INS+ cells from human stem cell-derived islet-like clusters (SC-islets) exhibited a closer resemblance to that observed in fetal islets. Transplantation of primary human islets or SC-islets, but not murine islets, lowered murine blood glucose to the human glycemic range, emphasizing the critical role of β cells in establishing species-specific glycemia. We further demonstrate the functional requirements of GLUT1 and GLUT2 in glucose uptake and insulin secretion through chemically inhibiting GLUT1 in primary islets and SCislets, and genetically disrupting GLUT2 in SC-islets. Finally, we developed a mathematical model to predict changes in glucose uptake and insulin secretion as a function of GLUT1/2 expression. Collectively, our findings illustrate the crucial roles of GLUTs in human β cells, and identify them as key components in establishing species-specific glycemic setpoints.

endocrinology & metabolism
Posttransplantation lymphoproliferative disorder of the stomach.

B. Jacobson,J. Paterson,D. Carr-Locke

DOI: https://doi.org/10.1016/S0016-5107(00)70298-7

IF: 10.396

2000-05-01

Gastrointestinal Endoscopy

Abstract:
Insulin Induces C2c12 Cell Proliferation and Apoptosis Through Regulation of Cyclin D1 and Bad Expression

Cheng-Juan Xiong,Ping-Fa Li,Yang-Liu Song,Li-Xiang Xue,Zhu-Qing Jia,Chun-Xia Yao,Qing-Xia Wei,Shu-Feng Zhang,Shan-Feng Zhang,Yan-Yan Zhang,Ji-Min Zhao,Tian-Qi Wang,Mao-Feng Guo,Ming-Xi Zang

DOI: https://doi.org/10.1002/jcb.24619

2013-01-01

Journal of Cellular Biochemistry

Abstract:Insulin is a secreted peptide hormone identified in human pancreas to promote glucose utilization. Insulin has been observed to induce cell proliferation and myogenesis in C2C12 cells. The precise mechanisms underlying the proliferation of C2C12 cells induced by insulin remain unclear. In this study, we observed for the first time that 10 nM insulin treatment promotes C2C12 cell proliferation. Additionally, 50 and 100 nM insulin treatment induces C2C12 cell apoptosis. By utilizing real-time PCR and Western blotting analysis, we found that the mRNA levels of cyclinD1 and BAD are induced upon 10 and 50 nM/100 nM insulin treatment, respectively. The similar results were observed in C2C12 cells expressing GATA-6 or PPARα. Our results identify for the first time the downstream targets of insulin, cyclin D1, and BAD, elucidate a new molecular mechanism of insulin in promoting cell proliferation and apoptosis.
Single cell glucose-stimulated insulin secretion assay using nanowell-in-microwell plates

Deasung Jang,Kerryn Matthews,Pan Deng,Samuel G Berryman,Cuilan Nian,Simon P Duffy,Francis C Lynn,Hongshen Ma

DOI: https://doi.org/10.1039/d4lc00413b

2024-08-30

Lab Chip

Abstract:Pancreatic β cells secrete insulin in response to elevated levels of glucose. Stem cell derived β (SCβ) cells aim to replicate this glucose-stimulated insulin secretion (GSIS) function, but current preparations cannot provide the same level of insulin as natural β cells. Here, we develop an assay to measure GSIS at the single cell level to investigate the functional heterogeneity of SCβ cells and donor-derived islet cells. Our assay involves randomly depositing single cells and insulin capture microbeads in open-top nanowells (40 × 40 × 55 μm3) fabricated on glass-bottom imaging microwell plates. Insulin secreted from single cells is captured on microbeads and then stained using a detection antibody. The nanowell microstructure limits diffusion of secreted insulin. The glass substrate provides an optically flat surface for quantitative microscopy to measure the concentration of secreted insulin. We used this approach to measure GSIS from SCβ cells and donor-derived islet cells after 15 minutes exposure to 3.3 mM and 16.7 mM glucose. Both cell types exhibited significant GSIS heterogeneity, where elite cells (<20%) produced the majority of the secreted insulin (55-78%). This assay provides an immediate readout of single cell glucose-stimulated insulin secretion in a flexible well plate-based format.
Carnosine scavenging of glucolipotoxic free radicals enhances insulin secretion and glucose uptake

Michael J. Cripps,Katie Hanna,Charlie Lavilla,Sophie R. Sayers,Paul W. Caton,Craig Sims,Luigi De Girolamo,Craig Sale,Mark D. Turner

DOI: https://doi.org/10.1038/s41598-017-13649-w

IF: 4.6

2017-10-17

Scientific Reports

Abstract:The worldwide prevalence of diabetes has risen to 8.5% among adults, which represents a staggering rise in prevalence from 4.7% in 1980. Whilst some treatments work by increasing insulin secretion, over time their effectiveness decreases. We aim to increase insulin secretion by developing strategies that work through mechanisms independent of current treatment options. Isolated CD1 mouse islets, INS-1 pancreatic β-cells, or C2C12 mouse myotubes were incubated in standard tissue culture media, or media supplemented with 28 mM glucose, 200 μM palmitic acid, and 200 μM oleic acid as a cellular model of diabetic glucolipotoxicity. Intracellular reactive species content was assayed using 2′,7′-dichlorofluorescein diacetate dye, inducible nitric oxide synthase levels determined by Western blot, 3-nitrotyrosine and 4-hydrpxnonenal both assayed by ELISA, insulin secretion quantified using ELISA or radioimmunoassay, and glucose uptake determined through 2-deoxy glucose 6 phosphate luminescence. Our data indicate that carnosine, a histidine containing dipeptide available through the diet, is an effective scavenger of each of the aforementioned reactive species. This results in doubling of insulin secretion from isolated mouse islets or INS-1 β-cells. Crucially, carnosine also reverses glucolipotoxic inhibition of insulin secretion and enhances glucose uptake into skeletal muscle cells. Thus, carnosine, or non-hydrolysable carnosine analogs, may represent a new class of therapeutic agent to fight type 2 diabetes.

multidisciplinary sciences
Naringenin and falcarinol stimulate glucose uptake and TBC1D1 phosphorylation in porcine myotube cultures

M. Rasmussen,K. Kristiansen,Sumangala Bhattacharya,L. Christensen,N. Oksbjerg,J. F. Young

Abstract:Insulin resistance in muscles is a major problem associated with Type 2 diabetes. Bioactive compounds of plant origin have long been known for possessing anti-diabetic properties. We have studied the effect of the bioactive compounds naringenin (dihydroflavonol) and falcarinol (polyacetylene) on glucose uptake (GU) in normal and insulin resistant primary porcine myotubes, in the presence and absence of insulin to identify signaling pathways mediating their effects on GU. The dependence on glucose transporter type 4 (Glut4) activity, insulin signaling and AMP- activated protein kinase (AMPK)-signaling was studied by using the Glut4 inhibitor indinavir, the phosphatidyl inositol-3 kinase (PI3K) and p38 mitogen activated protein kinase (MAPK) inhibitor wortmannin, and the AMPK inhibitor dorsomorphin (DM), respectively. Naringenin and falcarinol stimulated GU was attenuated in the presence of indinavir and wortmannin, indicating a dependence on Glut4 activity as well as PI3K and/or p38MAPK activity. By contrast, DM diminished GU induced by naringenin only, indicating that falcarinol-stimulated GU was independent of AMPK activity. Finally, we show that naringenin and falcarinol enhance phosphorylation of TBC1D1 suggesting that these compounds enhance translocation of Glut4 containing vesicles and thereby GU via a TBC1D1-dependent mechanism.

Medicine,Biology,Chemistry
Glucose Stimulation of Beta-Cell DNA Replication in the Intact Rat and in Pancreatic Islets in Suspension Culture: Effects of Alpha-Ketoisocaproic Acid, Dibutyryl Cyclic AMP, and 3-Isobutyl-1-Methylxanthine in the In Vitro System

John Logothetopoulos,Nancy Valiquette,David Cvet

DOI: https://doi.org/10.2337/diab.32.12.1172

IF: 7.7

1983-12-01

Diabetes

Abstract:DNA replication in pancreatic beta-cells was compared in intact rats maintained hyperglycemie by continuous glucose infusion up to 10 days and in rat islets maintained in suspension culture in RPM11640 medium up to 12 days. Replicative activity was evaluated by counting the proportion of labeled beta-cell nuclei after injection or addition of [3H]thymidine. In both experimental systems, DNA replication initially was markedly stimulated by high glucose; then it subsided, even though high levels of glucose were maintained. Culture of pancreatic islets in suspension permitted the study of various treatments on beta-cell DNA replication. Alpha-ketoisocaproic acid, a nonglycolytic substrate for the beta-cell, stimulated DNA replication. 3-Isobutyl-1-methylxanthine (IBMX), in the presence of 4 mM glucose, was a potent stimulator. In many instances the proportion of labeled beta-cell nuclei in islets cultured with IBMX exceeded that obtained with 25 mM glucose. Dibutyryl-cyclic AMP stimulated DNA replication but was not as effective as IBMX. Although the effect of IBMX markedly decreased during the second week of culture, IBMX was much more effective than 25 mM glucose in maintaining DNA replication persistently above basal (4 mM glucose) levels.

endocrinology & metabolism
Insulin Stimulates Glucose Uptake Via a Phosphatidylinositide 3-Kinase-linked Signaling Pathway in Bovine Mammary Epithelial Cells

K. Zhao,H. -Y. Liu,M. -M. Zhou,F. -Q. Zhao,J. -X. Liu

DOI: https://doi.org/10.3168/jds.2013-7773

IF: 4.225

2014-01-01

Journal of Dairy Science

Abstract:The aim of this study was to investigate the effects of insulin on glucose uptake in lactating bovine mammary epithelial cells (BMEC). Primary BMEC were cultured in Dulbecco's modified Eagle's medium/nutrient mixture F-12 and treated with different levels of insulin (0, 5, 50, and 500 ng/mL) for 48 h after a 24-h starvation without fetal calf serum. Compared with the control cells (0 ng of insulin/mL), cell proliferation was enhanced by insulin treatment at all tested levels. Insulin significantly increased glucose uptake at a concentration of 500 ng/mL. In addition, the protein synthesis inhibitor cycloheximide (0.5mg/mL) counteracted the insulin-elevated glucose uptake, thereby suggesting that newly synthesized transporter protein might take part in the insulin-induced glucose uptake. Furthermore, pretreatment of the cells with SB203580, an inhibitor of p38 mitogen-activated protein kinase, did not influence the insulin-induced glucose uptake, but LY294002, a specific inhibitor of phosphatidylinositide 3-kinase, significantly reduced the insulin-stimulated glucose uptake. These results indicated that insulin-induced glucose uptake in BMEC may involve the phosphatidylinositide 3-kinase- but not mitogen-activated protein kinase-mediated signaling pathways.
Interactions between myoblasts and macrophages under high glucose milieus result in inflammatory response and impaired insulin sensitivity

Wei Luo,Yue Zhou,Li-Ying Wang,Lei Ai

DOI: https://doi.org/10.4239/wjd.v15.i7.1589

2024-07-15

Abstract:Background: Skeletal muscle handles about 80% of insulin-stimulated glucose uptake and become the major organ occurring insulin resistance (IR). Many studies have confirmed the interactions between macrophages and skeletal muscle regulated the inflammation and regeneration of skeletal muscle. However, despite of the decades of research, whether macrophages infiltration and polarization in skeletal muscle under high glucose (HG) milieus results in the development of IR is yet to be elucidated. C2C12 myoblasts are well-established and excellent model to study myogenic regulation and its responses to stimulation. Further exploration of macrophages' role in myoblasts IR and the dynamics of their infiltration and polarization is warranted. Aim: To evaluate interactions between myoblasts and macrophages under HG, and its effects on inflammation and IR in skeletal muscle. Methods: We detected the polarization status of macrophages infiltrated to skeletal muscles of IR mice by hematoxylin and eosin and immunohistochemical staining. Then, we developed an in vitro co-culture system to study the interactions between myoblasts and macrophages under HG milieus. The effects of myoblasts on macrophages were explored through morphological observation, CCK-8 assay, Flow Cytometry, and enzyme-linked immunosorbent assay. The mediation of macrophages to myogenesis and insulin sensitivity were detected by morphological observation, CCK-8 assay, Immunofluorescence, and 2-NBDG assay. Results: The F4/80 and co-localization of F4/80 and CD86 increased, and the myofiber size decreased in IR group (P < 0.01, g = 6.26). Compared to Mc group, F4/80+CD86+CD206- cells, tumor necrosis factor-α (TNFα), inerleukin-1β (IL-1β) and IL-6 decreased, and IL-10 increased in McM group (P < 0.01, g > 0.8). In McM + HG group, F4/80+CD86+CD206- cells, monocyte chemoattractant protein 1, TNFα, IL-1β and IL-6 were increased, and F4/80+CD206+CD86- cells and IL-10 were decreased compared with Mc + HG group and McM group (P < 0.01, g > 0.8). Compered to M group, myotube area, myotube number and E-MHC were increased in MMc group (P < 0.01, g > 0.8). In MMc + HG group, myotube area, myotube number, E-MHC, GLUT4 and glucose uptake were decreased compared with M + HG group and MMc group (P < 0.01, g > 0.8). Conclusion: Interactions between myoblasts and macrophages under HG milieus results in inflammation and IR, which support that the macrophage may serve as a promising therapeutic target for skeletal muscle atrophy and IR.

Insulin-stimulated glucose uptake in C2C12 myoblasts.

Successful Β Cells Islet Regeneration in Streptozotocin-Induced Diabetic Baboons Using Ultrasound-Targeted Microbubble Gene Therapy with Cyclind2/cdk4/glp1

Successful β cells islet regeneration in streptozotocin-induced diabetic baboons using ultrasound-targeted microbubble gene therapy with cyclinD2/CDK4/GLP1.

Glucose Sensing by Skeletal Myocytes Couples Nutrient Signaling to Systemic Homeostasis.

A Transgenic Mouse Model to Study Glucose Transporter 4myc Regulation in Skeletal Muscle

Insulin-triggered repositioning of munc18c on syntaxin-4 in GLUT4 signalling

In vivo effects of focused shock waves on tumor tissue visualized by fluorescence staining techniques.

Method for the Detection of Insulin‐independent Glucose Uptake in Skeletal Muscle

Development of a Novel GLUT4 Translocation Assay for Identifying Potential Novel Therapeutic Targets for Insulin Sensitization.

Assessment of Tissue-Specific Glucose Uptake: Teaching an Old 2-DOG New Tricks

Molecular basis for insulin-stimulated GLUT4 translocation

Bi-directional transport of GLUT4 vesicles near the plasma membrane of primary rat adipocytes.

Glucose transporters are key components of the human glucostat

Posttransplantation lymphoproliferative disorder of the stomach.

Insulin Induces C2c12 Cell Proliferation and Apoptosis Through Regulation of Cyclin D1 and Bad Expression

Single cell glucose-stimulated insulin secretion assay using nanowell-in-microwell plates

Carnosine scavenging of glucolipotoxic free radicals enhances insulin secretion and glucose uptake

Naringenin and falcarinol stimulate glucose uptake and TBC1D1 phosphorylation in porcine myotube cultures

Glucose Stimulation of Beta-Cell DNA Replication in the Intact Rat and in Pancreatic Islets in Suspension Culture: Effects of Alpha-Ketoisocaproic Acid, Dibutyryl Cyclic AMP, and 3-Isobutyl-1-Methylxanthine in the In Vitro System

Insulin Stimulates Glucose Uptake Via a Phosphatidylinositide 3-Kinase-linked Signaling Pathway in Bovine Mammary Epithelial Cells

Interactions between myoblasts and macrophages under high glucose milieus result in inflammatory response and impaired insulin sensitivity